Sixth Annual BMRP Investigator Meeting
February 7-8, 2008
Los Angeles, California
(NOTE: You must have Adobe Reader software in order to open the presentation documents.)
- Invited Speakers:
- Altshuler, David, M.D., Ph.D.
Assistant Professor of Genetics and Medicine, Harvard Medical School; Department of Molecular Biology & Diabetes Unit, Massachusetts General Hospital (Boston, U.S.A.); Director, Program in Medical and Population Genetics, Broad Institute (Cambridge, Massachusetts, U.S.A.)
Presentation
- Daly, Mark J., Ph.D.
Assistant Professor of Medicine, Harvard Medical School (Boston, U.S.A.); Associate Member, Broad Institute (Cambridge, Massachusetts, U.S.A.)
“Recent developments in human genetics and risk pathways for Crohn’s disease”
Presentation
Scientific Summary of Meeting:
- Hawkey, Christopher, M.D.
Professor, University Hospital Nottingham (United Kingdom)
- Presentations By BMRP Investigators:
(partial list of talks and posters)
- Arsenescu, Razvan, M.D.
University of Kentucky (Lexington, U.S.A.)
"Adiponectin and the plant agonist Osmotin are beneficial in a murine model of colitis"
- Büning, Carsten, M.D.
Charité-Universitätsmedizin Berlin, Campus Mitte (Germany)
"Genes involved in epithelial integrity as risk factors for IBD?"
- Cao, Caroline, Ph.D.
Tufts University (Medford, Massachusetts, U.S.A.)
"Fiber optic tracking to improve inflammatory bowel disease diagnosis"
Abstract
Poster
- Clandinin, M. Tom, Ph.D.
University of Alberta (Edmonton, Canada)
"Milk-derived gangliosides as novel anti-inflammatory therapy for inflammatory bowel disease"
- Craig, Robert M., M.D.
Northwestern University (Illinois, U.S.A.)
"Immunoablation and hematopoietic stem cell therapy for refractory Crohn's disease"
Abstract
Presentation
- Cross, Raymond K., M.D., M.S.
University of Maryland (Baltimore, U.S.A.)
"Home telemanagement for patients with ulcerative colitis (UC HAT)"
Abstract
Presentation
- Fantini, Massimo, M.D., Ph.D.
Universita di Roma Tor Vergata (Italy)
"Interleukin-21 (IL-21) triggers inflammatory signals in the gut. Relevance for human inflammatory bowel diseases"
Abstract
-
- Hawkey, Chris J., M.D.
University of Nottingham (United Kingdom)
"Autologous stem cell transplantation: international Crohn's syndrome (ASTIC) trial"
Abstract
Presentation
- Hayee, Bu'Hussain, B.Sc.
University College London (United Kingdom)
"Injection of 32P-labelled E. coli into human subjects demonstrates impaired bacterial clearance in Crohn's disease"
Abstract
- Hugot, Jean-Pierre, M.D., Ph.D.
INSERM, Hopital Robert Debré (Paris, France)
"Identification and genetic analyses of genes coding for NOD2 partners"
Abstract
- Koide, Yukio, M.D., Ph.D.
Hamamatsu University (Japan)
"A randomized clinical trial of curcumin in the therapy of inflammatory bowel disease"
- Kokkotou, Efi, M.D., Ph.D.
Harvard Medical School (Boston, Massachusetts, U.S.A.)
"Melanin-concentrating hormone elicits proinflammatory responses in colonocytes and adipocytes"
Abstract
- Kwon, John H. M.D., Ph.D.
Johns Hopkins University (Baltimore, Maryland, U.S.A.)
"the differential expression of microRNA in ulcerative colitis patients and their regulation of MIP-2alpha expression"
- Lindsay, James O., Ph.D.
Queen Mary's School of Medicine and Dentistry (London, United Kingdom)
"Fructo-oligosaccharides in Crohn's disease: a prospective, randomized, double-blind, controlled trial"
Presentation
- Mahadevan, Uma, M.D.
University of California, San Francisco (U.S.A.)
"Genetic damage to sperm following treatment with azathioprine/6-mercaptopurine (AZA/6MP) in men with inflammatory bowel disease"
Abstract
Presentation
- Rampton, David, S., BM, DPhil
Queen Mary University of London (United Kingdom)
"Hypnotherapy for prevention of relapse in ulcerative colitis: a randomized, single blind, controlled clinical trial"
Abstract
- Rogler, Gerhard, M.D., Ph.D.
University Hospital of Zürich (Switzerland)
"Paraepithelial passage of adherent luminal bacterial and activation of intestinal macrophages in Crohn's disease"
Abstract
- Savidge, Tor, Ph.D.
University of Texas Medical Branch at Galveston (U.S.A.)
"To examine the therapeutic potential of a novel mucosal barrier-inducing factor in the treatment of Crohn's disease"
Abstract
- Smith, Jill P., M.D.
Pennsylvania State University (Hershey, U.S.A.)
"Safety and efficacy of Naltrexone for treatment of active Crohn's disease: phase 2 placebo-controlled trial"
- Suskind, David L., M.D.
University of Washington (Seattle, U.S.A.)
"Maternal microchimerism in inflammatory bowel disease"
- Thomson, John, MB ChB
University of Aberdeen (Scotland, United Kingdom)
"Assessment of non-pylori Helicobacter species in ulcerative colitis"
Abstract
- Tsao, Stephen K. K., MB ChB
University Hospitals of Leicester NHS Trust (United Kingdom)
"Epidermal growth factor – a new therapeutic approach"
Abstract
Presentation
- Vermeulen, Nathalie, M.Sc.
University Hospital Gasthuisberg (Leuven, Belgium)
"Identification of target antigens of antibodies in inflammatory bowel disease: protein microarray experiments identify Phla1 as a target antigen"
Abstract
Poster
- Visser, Lydia, Ph.D.
University of Groningen (The Netherlands)
"Ex vivo treatment of biopsies in inflammatory bowel disease with galectin-1"
- Zasloff, Michael, M.D., Ph.D.
Georgetown University (Washington, D.C., U.S.A.)
"Antimicrobial peptide expression and its relationship to commensal bacteria in the transplanted small bowel"
Abstract